Inhibrx Biosciences, Inc. logo INBX - Inhibrx Biosciences, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 3
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $325.00 DETAILS
HIGH: $325.00
LOW: $325.00
MEDIAN: $325.00
CONSENSUS: $325.00
UPSIDE: 211.71%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q2 2018 Q1 2017 Q4
Revenue
Revenue 0 0 0 1.3 0 0.1 0 0.1 0 1.6 0.1 0.0 0.0 0.3 0.3 0.7 0.9 2.8 2.5 0.9 0.9 2.8 5.8 3.3 0.9 0.3 0.8 1 7.0 2.3 2.5 2.5 0.3
Cost of Revenue 0.5 0.6 0 0.7 0.7 0.7 0.8 0 0.4 0.3 0 0.3 0.7 0.7 0.7 29.9 0 0 0 0 16.4 0 19.8 19.0 0 0.0 12.8 12.2 10.7 4.7 8.5 10.8 7.3
Gross Profit (0.5) (0.6) 0 0.6 (0.7) (0.6) (0.8) 0.1 (0.4) 1.3 0.1 (0.3) (0.7) (0.4) (0.4) (29.2) 0.9 2.8 2.5 0.9 (15.6) 2.8 (14.0) (15.6) 0.9 0.3 (12.0) (11.2) (3.6) (2.4) (6.0) (8.3) (7.0)
Operating Expenses
R&D Expenses 24.7 25.3 28.5 22.3 36.9 33.4 38.2 67.6 63.6 81.8 38.1 33.9 37.4 30.5 24.9 29.9 24.9 18.6 18.5 17.9 16.4 17.7 19.8 19.0 17.0 12.3 12.8 12.2 10.7 4.7 8.5 10.8 7.3
SG&A Expenses 5.7 5.6 5.3 6.4 6.0 16.7 7.8 93.4 9.9 7.8 7.9 7.2 6.4 5.3 5.3 5.4 5.1 3.6 2.8 2.9 3.0 2.2 1.6 1.5 1.5 4.4 1.5 1.6 1.5 1.7 1.0 0.9 0.9
Other Expenses 0 (0.6) 0 (0.7) (0.7) (0.7) 0 0 0 0 0 0 (5.2) (5.4) (5.3) 0.0 (0.0) 0 (0.0) 0.0 0.0 0 (4.5) (0.0) 0.0 0.0 (0.1) 0.0 0.0 0 0.0 0.0 0
Operating Expenses 30.4 30.4 33.8 28.0 42.2 49.3 46.0 161.0 73.5 89.6 45.9 41.1 43.8 35.8 30.3 35.3 29.9 22.2 21.3 20.7 19.4 19.9 21.4 20.5 18.5 16.7 13.8 11.6 10.6 1.7 9.2 11.4 0.9
Operating Income
Operating Income (30.9) (30.9) (33.8) (27.4) (42.9) (49.9) (46.8) (160.9) (73.8) (88.3) (45.8) (41.3) (43.8) (35.5) (30.0) (34.6) (29.0) (19.4) (18.8) (19.8) (18.6) (17.1) (15.6) (17.2) (17.6) (16.5) (13.0) (10.6) (3.6) (4.1) (6.7) (8.9) (7.9)
Interest Expense 3.5 3.2 3.2 3.1 2.7 0 0 5.4 8.1 8.2 8.1 7.9 5.1 5.3 5.3 3.1 2.3 1.8 1.8 0.9 0.7 0.5 4.4 3.4 2.5 2.3 2.7 0.5 0.2 0 0.4 0.5 0
Interest Income 1.0 1.3 1.8 2.1 2.3 2.0 2.9 2.7 3.3 4.7 2.3 2.4 5.1 5.3 5.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.5
Profitability
EBITDA (30.4) (30.4) (31.5) (24.9) (39.9) (47.2) (43.1) 1,863.8 (70.2) (88.0) (43.3) (38.8) (41.1) (35.5) (30.0) (34.3) (28.7) (19.1) (18.5) (19.5) (18.3) (16.8) (15.3) (14.2) (17.3) (16.5) (16.1) (10.6) (2.8) (3.9) (6.5) (8.7) (7.8)
EBIT (30.9) (30.9) (32.1) (25.5) (40.6) (47.9) (43.9) 1,863.4 (70.6) (88.3) (43.6) (39.1) (41.4) (35.6) (30.0) (34.6) (29.0) (19.4) (18.8) (19.8) (18.5) (17.1) (15.6) (14.5) (17.6) (16.8) (16.6) (10.6) (3.6) (4.1) (6.7) (8.9) (7.9)
Income Before Tax (33.4) (32.8) (35.3) (28.7) (43.3) (47.9) (43.9) 1,858.0 (78.7) (93.6) (51.8) (47.0) (48.9) (40.9) (35.3) (37.7) (31.3) (21.2) (20.6) (20.7) (19.3) (17.6) (20.0) (17.9) (20.1) (16.3) (19.3) (11.1) (3.8) (4.4) (7.0) (9.3) (8.4)
Income Tax Expense 0 0 0 0.0 0 0 0 0.0 0 (0.0) 0.0 0.0 (0.2) (0.0) 5.3 0.0 2.2 0 0 0 0.0 0.0 0.5 0 0 0 0.9 (0.0) 0 0.0 0.5 0.5 (8.4)
Net Income (33.4) (32.8) (35.3) (28.7) (43.3) (47.9) (43.9) 1,858.0 (78.7) (93.6) (51.8) (47.1) (48.7) (40.9) (40.6) (37.7) (33.5) (21.2) (20.6) (20.7) (19.3) (17.6) (20.5) (17.9) (20.1) (16.3) (20.2) (11.1) (3.8) (4.4) (7.2) (9.4) (7.9)
Per Share Data
EPS (Basic) -2.15 -2.11 -2.28 -1.85 -2.80 -3.31 -2.84 128.35 -1.44 -1.73 -1.10 -1.08 -1.12 -0.95 -1.04 -0.97 -0.86 -0.55 -0.54 -0.55 -0.51 -0.47 -0.77 -0.50 -0.70 -0.57 -0.70 -0.39 -0.13 -0.16 -0.25 -0.32 -0.44
EPS (Diluted) -2.15 -2.11 -2.28 -1.85 -2.80 -3.31 -2.84 125.48 -1.44 -1.73 -1.10 -1.08 -1.12 -0.95 -1.04 -0.97 -0.86 -0.55 -0.54 -0.55 -0.51 -0.47 -0.77 -0.50 -0.70 -0.57 -0.70 -0.39 -0.13 -0.16 -0.25 -0.32 -0.44
Shares Outstanding 15.6 15.5 15.5 15.5 15.5 14.5 15.5 14.5 54.6 54.0 47.2 43.6 43.6 43.3 39.1 39.0 39.0 38.6 37.9 37.8 37.7 37.7 26.8 35.7 28.8 28.8 28.8 28.8 28.8 27.9 28.8 28.8 18.2
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q2 2019 Q1 2018 Q4 2018 Q1 2017 Q4
Current Assets
Cash & Cash Equivalents 161.7 124.2 153.1 186.6 216.5 152.6 196.3 226.9 252.5 277.9 337.3 192.5 234.3 273.9 146.1 176.4 143.5 131.3 112.7 125.7 108.0 128.7 127.7 5.6 0.4 11.5 27.6 6.2 2.1 (13.5) 13.5
Short-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 26.9 0
Net Receivables 0.2 0.2 0.8 1.0 0.2 0.4 1.1 1.4 3.0 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.9 0.5 0.5 0.4 0.6 1.0 0.1 0 0.4 4.3 1.8 0.7 0 0.7
Inventory 0 0 0 0 0 0 0 0 0 0 (0.3) 0 (0.3) 0 (0.3) 0 5.9 (0.9) 5.1 4.4 4.4 (129.3) (1.0) 2.7 0 3.2 1.7 2.2 2.3 0 1.0
Other Current Assets 9.5 0.2 7.5 1.2 1.8 0.8 1.8 2.1 0.5 0.7 26.0 10.5 9.5 0.2 7.7 0.6 0.6 7.8 0.7 0.6 0.7 132.2 4.2 0.3 2.9 0.4 0.5 0.3 0.6 0 0.3
Total Current Assets 171.3 132.8 161.4 194.0 223.4 160.4 207.4 242.1 274.5 295.4 363.3 203.3 243.8 280.5 153.8 181.6 150.4 139.1 119.0 131.3 113.4 132.2 131.8 8.8 3.4 15.6 34.1 10.5 5.7 13.5 15.4
Non-Current Assets
Property, Plant & Equipment 8.2 9.3 10.3 11.3 12.4 13.5 8.4 9.6 9.5 9.4 6.3 6.7 6.8 7.2 7.9 8.4 8.9 9.5 9.9 10.4 10.9 11.3 11.5 11.7 11.9 10.7 11.2 10.8 2.6 0 1.8
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 4.4 4.4 5.7 6.8 6.8 6.8 6.7 6.7 4.6 3.2 3.2 3.2 3.2 3.2 3.2 3.2 1.8 1.8 0.2 0.2 0.2 0.2 0.2 0.8 0.3 0.2 3.4 2.8 1.7 (13.5) 0
Total Non-Current Assets 12.6 13.6 16.0 18.2 19.3 20.4 15.1 16.4 14.0 12.5 9.4 9.8 9.9 10.4 11.1 11.6 10.8 11.3 10.1 10.6 11.1 11.6 11.7 12.5 12.2 10.9 14.6 13.5 4.3 (13.5) 1.8
Total Assets 184.0 146.5 177.5 212.1 242.6 180.8 222.6 258.4 288.6 307.9 372.7 213.2 253.7 290.9 164.9 193.2 161.2 150.4 129.2 141.9 124.5 143.7 143.6 21.3 15.6 26.5 48.7 24.0 10.0 0 17.2
Current Liabilities
Account Payables 8.8 5.9 6.8 8.3 8.9 9.2 12.4 13.0 12.4 11.0 7.9 9.7 10.9 8.3 8.6 9.2 7.9 9.1 12.4 9.9 14.3 13.5 15.2 8.9 9.4 3.1 2.8 3.7 6.5 0 0.8
Short-Term Debt 2.4 2.3 2.2 0 0 1.6 0 0 3.6 0 0 2.0 1.9 1.9 1.8 1.8 1.7 1.7 1.6 1.6 1.5 1.5 1.9 1.4 0 4.7 7.7 9.1 5.9 0 5.2
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0.1 0.1 0.2 0.4 0.7 1.2 2.0 2.8 3.2 4.1 3.1 0 3.7 0 7.9 4.2 4.1 1.6 0 2.6
Other Current Liabilities 15.3 18.1 27.0 3.8 2.7 7.7 6.5 4.5 31.9 6.5 27.9 19.6 19.7 13.8 14.6 12.5 9.3 9.6 8.3 7.0 7.9 13.4 17.7 15.7 15.9 4.8 0.2 0.7 2.1 0 0.4
Total Current Liabilities 26.5 33.8 36.0 38.9 43.6 40.7 44.1 39.1 71.9 56.3 35.8 31.3 32.6 27.6 25.4 24.2 20.1 22.5 25.1 21.7 27.9 31.4 34.7 29.8 25.2 20.6 14.8 17.6 16.2 0 8.9
Non-Current Liabilities
Long-Term Debt 3.5 100.6 4.7 99.3 98.7 0 0 0 204.6 207.0 207.4 206.7 203.3 202.1 170.8 173.9 113.7 70.5 75.5 75.6 35.8 36.0 16.9 9.4 39.7 37.1 32.7 7.5 3.6 0 9.5
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.2) 0 0 (6.7) 0 0 0 0 0
Other Non-Current Liabilities 175.0 0 99.9 0 0 0 0 0 0 0 0 0 2.7 0 3.7 0 0 5.1 0.2 0.2 0.2 0.2 0.2 0.0 3.6 68.1 60.4 59.5 47.9 0 21.3
Total Non-Current Liabilities 178.5 104.7 104.7 104.6 104.6 6.5 0 0 205.1 208.1 207.4 206.7 205.9 205.2 174.5 173.9 113.7 75.6 75.8 75.9 36.1 36.9 17.1 10.8 43.4 99.5 93.2 67.0 51.4 0 30.7
Total Liabilities 205.0 138.5 140.6 143.6 148.2 47.2 44.1 39.1 277.0 264.4 243.1 238.0 238.6 232.8 199.9 198.1 133.8 98.1 101.0 97.6 63.9 68.3 51.8 40.5 68.6 120.1 108.0 84.6 67.6 0 39.7
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0
Retained Earnings (279.6) (246.2) (213.4) (178.1) (149.4) (106.1) (58.3) (14.4) (692.4) (613.7) (520.1) (468.3) (421.3) (372.4) (331.5) (296.1) (258.4) (227.1) (206.0) (185.4) (164.7) (145.4) (127.7) (109.5) (89.3) (69.3) (32.8) (21.7) (17.9) 0 (28.8)
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (143.6) (2.9) (23.2) (2.4) (2.1) (1.9) (1.7) (28.8) (1.0)
Total Stockholders' Equity (21.0) 8.0 36.8 68.6 94.4 133.6 178.5 219.4 11.6 43.5 129.6 (24.8) 15.1 58.1 (35.0) (4.9) 27.4 52.4 28.2 44.3 60.6 75.5 91.7 (19.2) (53.1) (93.6) (59.2) (60.6) (57.6) (1.4) (28.8)
Total Liabilities & Equity 184.0 146.5 177.5 212.1 242.6 180.8 222.6 258.4 288.6 307.9 372.7 213.2 253.7 290.9 164.9 193.2 161.2 150.4 129.2 141.9 124.5 143.7 143.6 21.3 15.6 26.5 48.7 24.0 10.0 (1.4) 17.2
Debt Metrics
Total Debt 5.9 107.0 7.0 106.8 106.5 8.0 1.8 2.2 210.9 210.1 207.4 208.6 205.9 207.1 172.6 175.7 115.4 72.1 77.2 77.2 37.3 37.5 18.8 10.8 39.7 41.7 40.4 16.6 9.5 0 14.7
Net Debt (155.8) (17.2) (146.1) (79.8) (110.0) (144.5) (194.5) (224.7) (41.6) (67.8) (130.0) 16.1 (28.3) (66.8) 26.6 (0.7) (28.0) (59.2) (35.5) (48.6) (70.7) (91.2) (108.9) 5.1 39.3 30.2 12.8 10.4 7.4 13.5 1.2
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q2 2018 Q1 2017 Q4
Operating Activities
Net Income (33.4) (32.8) (35.3) (28.7) (43.3) (47.9) (43.9) 1,828.6 (78.7) (93.6) (51.8) (47.1) (48.9) (40.9) (35.3) (37.7) (31.3) (21.2) (20.6) (20.7) (19.3) (17.6) (20.5) (17.9) (20.1) (16.3) (20.2) (11.1) (3.8) (4.4) (7.0) (9.3) (7.9)
Depreciation & Amortization 0.5 0.6 0.6 0.7 0.7 0.7 0.8 0.5 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.3 0.2 0.5 (0.4) 0.8 0.2 0.2 0.2 0.1
Stock-Based Compensation 0 2.7 3.2 2.8 2.5 3.0 3.0 47.5 6.4 6.4 6.5 0 0 5.4 4.7 5.3 5.1 4.2 3.5 4.0 3.4 1.4 1.3 1.3 1.1 1.1 1.0 0.9 0.9 0.3 1.8 0.3 0.4
Change in Working Capital (9.0) (1.7) (3.4) (5.8) 3.3 0.0 9.4 35.5 7.2 25.4 (11.0) (3.4) 1.4 3.0 (0.7) 4.1 (2.0) (2.6) 2.3 (6.5) (6.6) 0.1 (0.0) 3.1 9.4 0.1 11.4 (4.5) (3.5) (1.3) (8.1) 6.6 1.0
Other Non-Cash Items 3.9 1.1 1.1 1.1 1.0 0.5 0.5 (1,969.4) 1.7 4.6 1.7 7.9 7.3 1.7 0.2 1.1 0.9 (3.4) 0.8 0.6 0.6 0.5 4.6 4.6 1.9 5.3 2.9 1.3 0.1 (1.7) 0.1 0.2 (0.7)
Operating Cash Flow (38.0) (30.1) (33.8) (30.0) (35.9) (43.7) (30.3) (57.4) (63.0) (56.8) (54.2) (42.3) (39.9) (30.6) (30.8) (26.9) (26.9) (22.6) (13.7) (22.4) (21.6) (15.4) (13.9) (11.3) (7.4) (11.9) (0.8) (13.8) (5.6) (6.9) (13.0) (2.1) (7.0)
Investing Activities
Capital Expenditure 0 0 (0.0) 0 (0.0) (0.0) (0.2) (1.2) (1.1) (3.4) (0.8) (0.3) (0.0) (0.3) 0.0 (0.3) (0.1) (0.3) (0.2) (0.4) (0.0) (0.6) (0.3) (0.4) (0.1) (0.3) (0.7) (0.7) (0.1) (0.6) (0.5) (0.1) (0.2)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow 0 0 (0.0) 0 (0.0) (0.0) (0.2) (1.2) (1.1) (3.4) (0.8) (0.3) (0.0) (0.3) 0.0 (0.3) (0.1) (0.3) (0.2) (0.4) (0.0) (0.6) (0.3) (0.4) (0.1) (0.3) (0.7) (0.7) (0.1) (0.6) (0.5) (0.1) (0.2)
Financing Activities
Net Debt Issuance 75.0 0 0 0 100.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.5) (0.4) (0.1)
Other Financing Activities 0 0 0.4 0 (0.1) 33.0 0 0 0 0.9 199.9 0 0 158.7 0.5 60.2 39.2 41.5 0.8 40.5 1.0 17.0 136.2 16.9 (3.6) (0.4) (1.9) 35.9 9.8 6.7 7.6 (1.4) (1.3)
Financing Cash Flow 75.5 1.3 0.4 0 99.8 0 0 33.0 38.7 0.9 199.9 0.9 0.4 158.7 0.5 60.2 39.2 41.5 0.8 40.5 1.0 17.0 136.2 16.9 (3.6) (0.4) (1.9) 35.9 9.8 6.7 7.1 (1.8) (1.5)
Cash Position
Net Change in Cash 37.4 (28.9) (33.5) (30.0) 63.9 (43.7) (30.5) (25.6) (25.4) (59.4) 144.8 0 0 127.8 (30.3) 32.9 12.2 18.6 (13.0) 17.7 (20.7) 1.0 122.0 5.2 (11.1) (12.7) (3.4) 21.4 4.1 2.1 (6.4) (3.9) 13.5
Cash at Beginning 124.2 153.1 186.6 216.5 152.6 196.3 226.9 252.5 277.9 337.3 192.5 0 0 146.1 176.4 143.5 131.3 112.7 125.7 108.0 128.7 127.7 5.6 0.4 11.5 24.3 27.6 6.2 2.1 0 9.5 13.5 0
Cash at End 161.7 124.2 153.1 186.6 216.5 152.6 196.3 226.9 252.5 277.9 337.3 0 0 273.9 146.1 176.4 143.5 131.3 112.7 125.7 108.0 128.7 127.7 5.6 0.4 11.5 24.3 27.6 6.2 2.1 3.1 9.5 13.5
Free Cash Flow (38.0) (30.1) (33.8) (30.0) (35.9) (43.7) (30.5) (58.6) (64.2) (60.3) (55.1) (42.6) (40.0) (30.9) (30.8) (27.2) (27.1) (22.9) (13.8) (22.8) (21.7) (16.0) (14.2) (11.7) (7.5) (12.3) (1.5) (14.5) (5.7) (7.5) (13.5) (2.2) (7.2)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q2 2018 Q1 2017 Q4
Income Statement
Revenue 0 0 0 1.3 0 0.1 0 0.1 0 1.6 0.1 0.0 0.0 0.3 0.3 0.7 0.9 2.8 2.5 0.9 0.9 2.8 5.8 3.3 0.9 0.3 0.8 1 7.0 2.3 2.5 2.5 0.3
Gross Profit (0.5) (0.6) 0 0.6 (0.7) (0.6) (0.8) 0.1 (0.4) 1.3 0.1 (0.3) (0.7) (0.4) (0.4) (29.2) 0.9 2.8 2.5 0.9 (15.6) 2.8 (14.0) (15.6) 0.9 0.3 (12.0) (11.2) (3.6) (2.4) (6.0) (8.3) (7.0)
Operating Income (30.9) (30.9) (33.8) (27.4) (42.9) (49.9) (46.8) (160.9) (73.8) (88.3) (45.8) (41.3) (43.8) (35.5) (30.0) (34.6) (29.0) (19.4) (18.8) (19.8) (18.6) (17.1) (15.6) (17.2) (17.6) (16.5) (13.0) (10.6) (3.6) (4.1) (6.7) (8.9) (7.9)
Net Income (33.4) (32.8) (35.3) (28.7) (43.3) (47.9) (43.9) 1,858.0 (78.7) (93.6) (51.8) (47.1) (48.7) (40.9) (40.6) (37.7) (33.5) (21.2) (20.6) (20.7) (19.3) (17.6) (20.5) (17.9) (20.1) (16.3) (20.2) (11.1) (3.8) (4.4) (7.2) (9.4) (7.9)
EPS (Diluted) -2.15 -2.11 -2.28 -1.85 -2.80 -3.31 -2.84 125.48 -1.44 -1.73 -1.10 -1.08 -1.12 -0.95 -1.04 -0.97 -0.86 -0.55 -0.54 -0.55 -0.51 -0.47 -0.77 -0.50 -0.70 -0.57 -0.70 -0.39 -0.13 -0.16 -0.25 -0.32 -0.44
Balance Sheet
Cash & Equivalents 161.7 124.2 153.1 186.6 216.5 152.6 196.3 226.9 252.5 277.9 337.3 192.5 234.3 273.9 146.1 176.4 143.5 131.3 112.7 125.7 108.0 128.7 127.7 5.6 0.4 11.5 27.6 6.2 2.1 (13.5) 13.5
Total Assets 184.0 146.5 177.5 212.1 242.6 180.8 222.6 258.4 288.6 307.9 372.7 213.2 253.7 290.9 164.9 193.2 161.2 150.4 129.2 141.9 124.5 143.7 143.6 21.3 15.6 26.5 48.7 24.0 10.0 0 17.2
Total Debt 5.9 107.0 7.0 106.8 106.5 8.0 1.8 2.2 210.9 210.1 207.4 208.6 205.9 207.1 172.6 175.7 115.4 72.1 77.2 77.2 37.3 37.5 18.8 10.8 39.7 41.7 40.4 16.6 9.5 0 14.7
Stockholders' Equity (21.0) 8.0 36.8 68.6 94.4 133.6 178.5 219.4 11.6 43.5 129.6 (24.8) 15.1 58.1 (35.0) (4.9) 27.4 52.4 28.2 44.3 60.6 75.5 91.7 (19.2) (53.1) (93.6) (59.2) (60.6) (57.6) (1.4) (28.8)
Cash Flow
Operating Cash Flow (38.0) (30.1) (33.8) (30.0) (35.9) (43.7) (30.3) (57.4) (63.0) (56.8) (54.2) (42.3) (39.9) (30.6) (30.8) (26.9) (26.9) (22.6) (13.7) (22.4) (21.6) (15.4) (13.9) (11.3) (7.4) (11.9) (0.8) (13.8) (5.6) (6.9) (13.0) (2.1) (7.0)
Capital Expenditure 0 0 (0.0) 0 (0.0) (0.0) (0.2) (1.2) (1.1) (3.4) (0.8) (0.3) (0.0) (0.3) 0.0 (0.3) (0.1) (0.3) (0.2) (0.4) (0.0) (0.6) (0.3) (0.4) (0.1) (0.3) (0.7) (0.7) (0.1) (0.6) (0.5) (0.1) (0.2)
Free Cash Flow (38.0) (30.1) (33.8) (30.0) (35.9) (43.7) (30.5) (58.6) (64.2) (60.3) (55.1) (42.6) (40.0) (30.9) (30.8) (27.2) (27.1) (22.9) (13.8) (22.8) (21.7) (16.0) (14.2) (11.7) (7.5) (12.3) (1.5) (14.5) (5.7) (7.5) (13.5) (2.2) (7.2)